Effective Elimination of Acute Myeloid Leukemic Cells by Recombinant Bispecific Antibody Derivatives Directed Against CD33 and CD16-Reference-Cited by-同舟云学术

Effective Elimination of Acute Myeloid Leukemic Cells by Recombinant Bispecific Antibody Derivatives Directed Against CD33 and CD16

Published:2010-07 Issue:6 Volume:33 Page:599-608
ISSN:1524-9557
Container-title:Journal of Immunotherapy
language:en
Short-container-title:

Author:

Singer Heiko,Kellner Christian,Lanig Harald,Aigner Michael,Stockmeyer Bernhard,Oduncu Fuat,Schwemmlein Michael,Stein Christoph,Mentz Kristin,Mackensen Andreas,Fey Georg H.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology,Immunology,Immunology and Allergy

Reference48 articles.

1. Cancer statistics, 2008;Jemal;CA Cancer J Clin,2008

3. High-dose cytosine arabinoside in the treatment of acute myeloid leukemia: review of three randomized trials;Kern;Cancer,2006

4. Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B;Mayer;N Engl J Med,1994

5. Postremission treatment of elderly patients with acute myeloid leukemia in first complete remission after intensive induction chemotherapy: results of the multicenter randomized Acute Leukemia French Association (ALFA) 9803 trial;Gardin;Blood,2007

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting natural killer cells: from basic biology to clinical application in hematologic malignancies;Experimental Hematology & Oncology;2024-02-23

2. Revolutionizing cancer immunotherapy: unleashing the potential of bispecific antibodies for targeted treatment;Frontiers in Immunology;2023-12-01

3. NK cell defects: implication in acute myeloid leukemia;Frontiers in Immunology;2023-05-09

4. Natural killer cell immunotherapy in glioblastoma;Discover Oncology;2022-10-28

5. A bispecific, crosslinking lectibody activates cytotoxic T cells and induces cancer cell death;2022-09-21